Evaluation of the Safety and Efficacy of TLD in Patients with COPD
- Conditions
- COPD
- Interventions
- Device: Targeted Lung Denervation (TLD)Other: Optimal Medical Care
- First Posted Date
- 2018-08-20
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- Nuvaira, Inc.
- Target Recruit Count
- 464
- Registration Number
- NCT03639051
- Locations
- 🇺🇸
University of Alabama at Birmingham (UAB) Lung Health Center, Birmingham, Alabama, United States
🇺🇸HonorHealth, Phoenix, Arizona, United States
🇺🇸UC Davis, Sacramento, California, United States
Discovery of the Impact of Targeted Lung Denervation (TLD) on the Severe and Very Severe COPD Population
- Conditions
- COPD
- Interventions
- Device: Targeted Lung Denervation (TLD)
- First Posted Date
- 2017-07-11
- Last Posted Date
- 2019-02-18
- Lead Sponsor
- Nuvaira, Inc.
- Registration Number
- NCT03213080
Evaluating the Safety and Feasibility of TLD for the Treatment of Severe Asthma
- Conditions
- Asthma
- Interventions
- Device: Targeted Lung Denervation (TLD)
- First Posted Date
- 2016-08-19
- Last Posted Date
- 2022-04-12
- Lead Sponsor
- Nuvaira, Inc.
- Target Recruit Count
- 2
- Registration Number
- NCT02872298
- Locations
- 🇫🇷
CHU de Grenoble, Grenoble, France
🇬🇧Queen Elizabeth University Hospital, Glasgow, Scotland, United Kingdom
🇩🇪Thoraxklinik Heidelberg, Heidelberg, Germany
Targeted Lung Denervation for Patients With Moderate to Severe COPD
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Interventions
- Device: Holairaâ„¢ Lung Denervation System with energy deliveryDevice: Holairaâ„¢ Lung Denervation System without energy delivery
- First Posted Date
- 2014-02-10
- Last Posted Date
- 2022-04-13
- Lead Sponsor
- Nuvaira, Inc.
- Target Recruit Count
- 128
- Registration Number
- NCT02058459
- Locations
- 🇦🇹
Otto-Wagner-Spital, Vienna, Austria
🇦🇹AKH Allgemeines Krankenhaus der Stadt Linz GmbH, Linz, Austria
🇫🇷CHU de Strasbourg, Strasbourg, France
Evaluation of the IPS System for TLD Therapy in Patients With COPD
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Interventions
- Device: IPS System
- First Posted Date
- 2012-10-30
- Last Posted Date
- 2016-09-23
- Lead Sponsor
- Nuvaira, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT01716598
- Locations
- 🇫🇷
Centre Hospitalier et Universitaire de Grenoble, Grenoble, France
🇫🇷Centre Hospitalier University de Reims, Reims, France
🇫🇷Nouvel Hopital Civil, Strasbourg, France
Innovative Pulmonary Solutions (IPS) System for Targeted Lung Denervation
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Interventions
- Device: TLD Therapy (IPS SystemTM)
- First Posted Date
- 2011-12-01
- Last Posted Date
- 2016-09-23
- Lead Sponsor
- Nuvaira, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT01483534
- Locations
- 🇿🇦
Panorama Medi-Clinic, Panorama, Cape Town, South Africa
🇳🇱University Medical Center Groningen (UMCG), Groningen, Netherlands
🇿🇦Stellenbosch University, Capetown, South Africa